110 related articles for article (PubMed ID: 2647277)
1. ras oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix.
Sagae S; Kuzumaki N; Hisada T; Mugikura Y; Kudo R; Hashimoto M
Cancer; 1989 Apr; 63(8):1577-82. PubMed ID: 2647277
[TBL] [Abstract][Full Text] [Related]
2. Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix.
Sagae S; Kudo R; Kuzumaki N; Hisada T; Mugikura Y; Nihei T; Takeda T; Hashimoto M
Cancer; 1990 Jul; 66(2):295-301. PubMed ID: 2196111
[TBL] [Abstract][Full Text] [Related]
3. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical studies on epidermal growth factor receptor and the myc oncogene product in squamous cell carcinoma of the uterine cervix].
Yamasaki M; Maruo T; Akahori T; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jan; 40(1):51-8. PubMed ID: 3280708
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and immunoblot analyses of ras-p21 expression in lung carcinomas.
Koshiishi Y; Noguchi M; Nakajima T; Hirohashi S; Shimosato Y; Hayata Y
Acta Pathol Jpn; 1989 Oct; 39(10):643-7. PubMed ID: 2686349
[TBL] [Abstract][Full Text] [Related]
6. ras and c-myc oncoproteins during tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Tumori; 1998; 84(5):583-8. PubMed ID: 9862521
[TBL] [Abstract][Full Text] [Related]
7. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer.
Nishio H; Nakamura S; Horai T; Ikegami H; Matsuda M
Cancer; 1992 Mar; 69(5):1130-6. PubMed ID: 1310887
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
[TBL] [Abstract][Full Text] [Related]
10. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance on expression of the ras gene product P21 in human cervical carcinoma tissues].
Huang G; Lu S; Mao T; Song Y
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):61-4. PubMed ID: 1398628
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions.
Nakajima K; Kuzumaki N; Oda A; Kobayashi H; Katoh H; Tanabe T
Oncology; 1989; 46(4):260-5. PubMed ID: 2662090
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
Ueda M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1401-8. PubMed ID: 2685140
[TBL] [Abstract][Full Text] [Related]
14. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
15. Ha-ras oncogene product in human oral squamous cell carcinoma.
Oku N; Shimada K; Itoh H
Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
[TBL] [Abstract][Full Text] [Related]
16. Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma.
Ruol A; Stephens JK; Michelassi F; Segalin A; Chiarelli S; Peracchia A; Skinner DB; Little AG
J Surg Oncol; 1990 Jul; 44(3):142-5. PubMed ID: 2196399
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis.
Tanaka T; Slamon DJ; Shimoda H; Waki C; Kawaguchi Y; Tanaka Y; Ida N
Cancer Res; 1988 Feb; 48(4):1030-4. PubMed ID: 3276397
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the rasH oncogene and its p21 product in chemically induced skin tumors and tumor-derived cell lines.
Harper JR; Reynolds SH; Greenhalgh DA; Strickland JE; Lacal JC; Yuspa SH
Carcinogenesis; 1987 Dec; 8(12):1821-5. PubMed ID: 2824083
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
Sonoda K; Kaku T; Kamura T; Nakashima M; Watanabe T; Nakano H
Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
